| Literature DB >> 35149377 |
Ling Gao1, Suhuan Mei2, Haile Ma3, Xiumin Chen4.
Abstract
Ultrasound and plant extract are two green approaches that have been used to synthesize gold nanoparticles (AuNPs); however, how the combination of ultrasound and citrus peel extract (CPE) affects the structure characteristics and the bioactivity of AuNPs remains unknown. Here we investigated the effects of ultrasound conditions on the particle size, stability, yield, phenolic encapsulation efficacy, and the anti-inflammatory activity of AuNPs. The results showed that temperature was positively correlated to the particle size and the anti-inflammatory activity of synthesized AuNPs. Increasing the power intensity significantly decreased the particle size, while increased the change of total phenolic content (ΔTPC) in the reaction mixture. The increase of ΔTPC caused the enhanced anti-inflammatory activity of AuNPs. The AuNPs synthesized with or without ultrasound treatment were characterized using UV-Vis, DLS, SEM, TEM, EDS, XRD, and FT-IR. The result verified the formation of negatively charged, spherical, stable, and monodispersed AuNPs. AuNPs synthesized with ultrasound (AuNPs-U) has smaller particle size (13.65 nm vs 16.80 nm), greater yield and anti-inflammatory activity (IC50, 82.91 vs 157.71 μg/mL) than its non-ultrasound counterpart (AuNPs-NU). HPLC analysis showed that hesperidin was the key reductant for the synthesis of AuNPs. AuNPs-U also inhibited the mRNA and protein expression of iNOS and COX-2 in the LPS-induced Raw 264.7 cells. Our research elucidates the relationship between the reaction conditions and the structure characteristics and the anti-inflammatory activity of AuNPs synthesized using CPE with the help of ultrasound, thereafter, provides a feasible and economic way to synthesize AuNPs that can be used to ameliorate inflammation.Entities:
Keywords: Anti-inflammation; AuNPs; Citrus peel; Green synthesis; Ultrasonication
Mesh:
Substances:
Year: 2022 PMID: 35149377 PMCID: PMC8841883 DOI: 10.1016/j.ultsonch.2022.105940
Source DB: PubMed Journal: Ultrason Sonochem ISSN: 1350-4177 Impact factor: 7.491
Fig. 1UV–Vis absorption spectra of AuNPs synthesized by CPE under different ultrasound conditions.
The impacts of ultrasonic conditions on the MPS, Zeta potential, ΔTPC, and NO inhibitory activity (IC50) of AuNPs.
| Ultrasonic conditions | Levels | MPS | Zeta potential | ΔTPC | IC50 |
|---|---|---|---|---|---|
| Temperature | 50 | 29.77 ± 0.36d | −40.19 ± 1.03b | 30.42 ± 2.13a | 305.21 ± 0.57a |
| 57.5 | 67.07 ± 2.06b | −34.45 ± 2.74a | 28.97 ± 1.08a | 139.64 ± 4.62d | |
| 65 | 76.35 ± 7.14a | −44.26 ± 0.81bc | 28.10 ± 3.44a | 165.91 ± 4.86c | |
| 72.5 | 54.54 ± 0.78c | −47.06 ± 1.08c | 30.75 ± 2.20a | 119.33 ± 5.07e | |
| 80 | 69.95 ± 2.05b | −40.93 ± 1.08b | 27.02 ± 2.69a | 200.20 ± 10.48b | |
| Mass ratio | 15 | 56.76 ± 0.25 cd | −48.28 ± 2.43abc | 44.18 ± 3.98a | 127.41 ± 6.55b |
| 20 | 67.37 ± 4.57b | −45.91 ± 0.99a | 34.10 ± 1.51b | 108.71 ± 1.49b | |
| 25 | 93.87 ± 4.08a | −51.21 ± 2.59c | 29.79 ± 0.17b | 155.01 ± 13.11a | |
| 30 | 54.54 ± 0.78d | −47.06 ± 1.08ab | 30.75 ± 2.20b | 119.33 ± 5.07b | |
| 35 | 61.88 ± 5.25bc | −50.13 ± 0.98bc | 19.05 ± 1.31c | 156.80 ± 9.79a | |
| pH | 6 | 61.02 ± 2.06bc | −27.28 ± 0.71a | 32.33 ± 3.50a | 116.75 ± 0.60b |
| 7 | 55.49 ± 5.45bc | –32.94 ± 1.26b | 24.78 ± 1.56b | 112.50 ± 5.53bc | |
| 8 | 67.37 ± 4.57ab | −45.91 ± 0.99c | 34.10 ± 1.51a | 108.71 ± 1.49bc | |
| 9 | 54.79 ± 5.08c | −46.35 ± 1.39c | 27.23 ± 1.48ab | 103.69 ± 3.27c | |
| 10 | 75.41 ± 4.50a | −44.23 ± 1.69c | 30.18 ± 4.45ab | 130.22 ± 3.99a | |
| Time | 10 | 49.91 ± 2.52c | −40.86 ± 3.04b | 43.70 ± 2.32a | 98.06 ± 6.19c |
| 15 | 54.79 ± 5.08c | −46.35 ± 1.39c | 27.23 ± 1.48b | 103.69 ± 3.27c | |
| 20 | 47.32 ± 1.83c | −37.64 ± 1.98ab | 16.53 ± 0.78c | 151.57 ± 9.98b | |
| 25 | 88.15 ± 4.38b | −37.07 ± 1.48ab | 17.65 ± 0.49c | 173.16 ± 4.53a | |
| 30 | 100.61 ± 0.17a | –32.89 ± 0.82a | 17.14 ± 1.14c | 134.76 ± 9.12b | |
| Power | 60 | 125.36 ± 4.40a | −34.41 ± 1.53a | 36.86 ± 1.21c | 130.98 ± 7.08ab |
| 90 | 67.70 ± 1.93b | −36.85 ± 2.52ab | 41.06 ± 2.61bc | 129.89 ± 8.14ab | |
| 120 | 49.91 ± 2.52c | −40.86 ± 3.04b | 43.70 ± 2.32abc | 98.06 ± 6.19c | |
| 150 | 67.52 ± 4.81b | −35.22 ± 2.05ab | 47.85 ± 3.57ab | 117.04 ± 2.45b | |
| 180 | 66.55 ± 4.90b | −37.37 ± 1.94ab | 52.07 ± 5.82a | 136.41 ± 6.48a |
MPS: mean particle size. Data were expressed as mean ± SD; Means do not share letters denote significant difference at P < 0.05.
The ultrasound conditions are as follows: ultrasound frequency = 40 kHz, mass ratio = 30:1, pH = 8, ultrasound time = 15 min, ultrasonic power = 120 W, ultrasound temperature = 50–80 °C.
The ultrasound conditions are as follows: ultrasound frequency = 40 kHz, ultrasound temperature = 72.5 °C, pH = 8, ultrasound time = 15 min, ultrasonic power = 120 W, the mass ratio = 15–35.
The ultrasound conditions are as follows: ultrasound frequency = 40 kHz, ultrasound temperature = 72.5 °C, the mass ratio = 20, ultrasound time = 15 min, ultrasonic power = 120 W, pH = 6–10.
The ultrasound conditions are as follows: ultrasound frequency = 40 kHz, ultrasound temperature = 72.5 °C, the mass ratio = 20, pH = 9, ultrasonic power = 120 W, ultrasound time = 10–30 min.
The ultrasound conditions are as follows: ultrasound frequency = 40 kHz, ultrasound temperature = 72.5 °C, the mass ratio = 20, pH = 9, ultrasound time = 10 min, ultrasound power = 60–180 W.
Fig. 2Correlation of the attributes of AuNPs synthesized by CPE under different conditions.
Fig. 3Characterization of AuNPs synthesized by CPE. (A) UV–Vis absorption spectroscopy of CPE, AuNPs-U and AuNPs-NU, (B) UV–Vis absorption spectroscopy of AuNPs after storage for four months.
Fig. 4Characterization of AuNPs synthesized by CPE. (A) Zeta potential, (B) Particle size distribution, (C) SEM, (D) FT-TEM.
Fig. 5Characterization of AuNPs synthesized by CPE. (A) EDS, (B) XRD, (C) FT-IR.
Fig. 6The HPLC chromatograph of phytochemical standards (A), CPE before synthesis (B) and CPE after synthesis (C) at 280 nm. Compounds: 1, Chlorogenic acid; 2, Caffeic acid; 3, P-coumaric acid; 4, Ferulic acid; 5, Narirutin; 6, Hesperidin; 7, Naringenin; 8, Hesperetin; 9, Nobiletin; 10, Tangeretin.
The impacts of ultrasound on the change of phenolic substance on AuNPs.
| Treatment | Chlorogenic acid | Ferulic acid(μg/mL) | Narirutin | Hesperidin(μg/mL) | Nobiletin | |
|---|---|---|---|---|---|---|
| Ultrasonic | Before | 2.10 ± 0.03 | 1.06 ± 0.09 | 41.66 ± 0.17 | 40.66 ± 0.22 | 1.38 ± 0.09 |
| After | 1.06 ± 0.13 | N.D. | 28.85 ± 2.41 | 1.18 ± 0.91 | 0.93 ± 0.11 | |
| Change % | 49.52 ± 6.27 | 100.00 ± 0.00 | 27.83 ± 2.79 | 97.91 ± 2.12 | 32.65 ± 5.59 | |
| Non-ultrasonic | Before | 1.95 ± 0.04 | 0.93 ± 0.01 | 38.56 ± 0.25 | 39.90 ± 0.64 | 1.22 ± 0.03 |
| After | 0.86 ± 0.05 | N.D. | 27.38 ± 4.42 | 0.33 ± 0.19 | 0.71 ± 0.11 | |
| Change % | 55.81 ± 2.56 | 100.00 ± 0.00 | 23.11 ± 5.22 | 99.18 ± 0.47 | 41.16 ± 1.90 | |
Data were expressed as mean ± SD. N.D.: not detected.
Fig. 7Effects of AuNPs synthesized with or without ultrasound treatment on nitric oxide production and percentage inhibition in LPS-induced Raw 264.7 cells. (A) AuNPs-U, (B) AuNPs-NU. Raw264.7 cells were pre-treated with the indicated concentrations of samples for 1 h, and then stimulated with LPS (0.1 μg/mL) for 24 h. Error bars represent the standard deviation (n ≥ 3). ### denotes P < 0.001 when compared positive (+) to negative (-) control. Data do not share same alphabet letter denote significant difference (P < 0.05).
Fig. 8Effects of AuNPs-U on iNOS and COX-2 expressions in LPS-induced Raw264.7 cells. A, iNOS mRNA; B, COX-2 mRNA; C, iNOS protein; D, COX-2 protein. Raw264.7 cells were pre-treated with the indicated concentrations of samples for 1 h, and then stimulated with LPS (0.1 μg/mL) for 24 h. Error bars represent the standard deviation (n ≥ 3). ### denotes P < 0.001 when compared positive (+) to negative (-) control. Data do not share same alphabet letter denote significant difference (P < 0.05).